Tina Nova, Ph.D.

Director

Dr. Nova is a life science industry veteran with extensive experience building and leading novel genomics-based businesses. She currently serves as president and chief executive officer of Decipher Biosciences, Inc., a molecular genomics company focused on prostate and bladder cancers. Previously, she was president and CEO of Molecular Stethoscope, and senior vice president and general manager of Illumina’s oncology business unit. From 2000 to 2014, Dr. Nova was a co-founder, president and chief executive officer of Genoptix Medical Laboratory, which was purchased by Novartis Pharmaceuticals. She has also held senior positions with Nanogen, Ligand Pharmaceuticals and Hybritech.

She currently serves on the board of directors of Arena Pharmaceuticals and Veracyte and is vice chairman of the board of directors of Rady Children’s Institute for Genomic Medicine, part of Rady Children’s Hospital-San Diego.

Dr. Nova holds a B.S. degree in Biological Sciences from the University of California, Irvine where she graduated with honors and a Ph.D. in Biochemistry from the University of California, Riverside.